Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: A case report

Clinical Rheumatology

Volumn 23, Issue 5, 2004, Pages 456-459

  Kanazawa, Masato ^a   Wada, Yoko ^a,b,d   Ohno, Tsukasa ^a   In, Hian ^a   Yahata, Kazuaki ^a   Izumi, Junko ^a   Tanaka, Hisao ^a   Ito, Satoshi ^b   Ueno, Mitsuhiro ^b   Nakano, Masaaki ^c   Gejyo, Fumitake ^b  

^a Nagaoka Chuo General Hospital   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d Niigata Prefectural Senami Hospital   (Japan)

Author keywords

Antineutrophil cytoplasmic antibodies against proteinase 3; Antioxidized LDL antibody; Atherosclerosis; Malondialdehyde modified LDL; Mixed connective tissue disease

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; PREDNISOLONE; PROBUCOL; RIBONUCLEOPROTEIN ANTIBODY; VALPROIC ACID;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; BRAIN INFARCTION; CASE REPORT; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EDEMA; FACE DISORDER; FEMALE; FINGER; FOCAL EPILEPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MIXED CONNECTIVE TISSUE DISEASE; MUSCLE SPASM; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RISK FACTOR; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTERIOSCLEROSIS; ASPIRIN; AUTOANTIBODIES; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MYELOBLASTIN; PREDNISOLONE; PROBUCOL; SERINE ENDOPEPTIDASES; TREATMENT OUTCOME; VALPROIC ACID; WEGENER GRANULOMATOSIS;

EID: 6344262431     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0911-x     Document Type: Article

References (21)

1. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
2. Manzi S, Wasko MC (2000) Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 59:321-325
3. Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Isomaki H (1995) Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 22:1065-1067
4. Ward MM (1999) Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 42:338-346
5. Kumeda Y, Inaba M, Goto H et al. (2002) Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 46:1489-1497
6. Manzi S, Selzer F, Sutton-Tyrrell K et al. (1999) Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arhritis Rheum 42:51-60
7. Steinerova A, Racek J, Strozicky F, Zima T, Fialova L, Lapin A (2001) Antibodies against oxidized LDL - theory and clinical use. Physiol Res 50:131-141
8. Kasukawa R, Tojo T, Miyawaki S (1987) Preliminary diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (ed) Mixed connective tissue disease and antinuclear antibodies. Elsevier, Amsterdam, pp 41-47
9. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148-159
10. Graf WD, Milstein JM, Sherry DD (1993) Stroke and mixed connective tissue disease. J Child Neurol 8: 256-259
11. Kallenberg CG, Mulder AH, Tervaert JW (1992) Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 93: 675-682
12. Bartunkova J, Tesar V, Sediva A (2003) Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies. Clin Immunol 106:73-82
13. de Groot K, Schmidt DK, Arlt AC, Gross WL, Reinhold-Keller E (2001) Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 58: 1215-1221
14. Salonen JT, Yla-Herttuala S, Yamamoto R et al. (1992) Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883-887
15. Hulthe J, Fagerberg B (2002) Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study). Arterioscler Thromb Vasc Biol 22:1162-1167
16. Savolainen A, von Essen R, Leikola J et al. (1995) Antibodies against oxidised low-density lipoprotein in juvenile chronic arthritis. Scand J Rheumatol 24:209-211
17. George J, Harats D, Gilburd B, Levy Y, Langevitz P, Shoenfeld Y (1999) Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis. Lupus 8:220-226
18. Herrick AL, Illingworth KJ, Hollis S, Gomez-Zumaquero JM, Tinahones FJ (2001) Antibodies against oxidized low-density lipoprotein in systemic sclerosis. Rheumatology 40:401-405
19. Swets BP, Brouwer DA, Tervaert JW (2001) Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL. Clin Exp Immunol 124: 163-167
20. Bares M, Muchova M, Dufek M, Litzman J, Krupa P, Rektor I (2002) Wegener's granulomatosis: ischemic stroke as the first clinical manifestation (case study). J Neurol 249:1593-1594
21. de Roux-Serratrice C, Serratrice J, Granel B et al. (2002) Periaortitis heralding Wegener's granulomatosis. J Rheumatol 29:392-394